-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Covetrus (NASDAQ:CVET) Stock Rating Upgraded by TheStreet
Covetrus (NASDAQ:CVET) Stock Rating Upgraded by TheStreet
TheStreet upgraded shares of Covetrus (NASDAQ:CVET – Get Rating) from a d+ rating to a c- rating in a report published on Wednesday morning, TheStreetRatingsTable reports.
Separately, Stifel Nicolaus downgraded Covetrus from a buy rating to a hold rating and set a $22.00 target price for the company. in a report on Monday, June 13th. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Hold and an average target price of $21.40.
Get Covetrus alerts:Covetrus Stock Down 0.1 %
CVET opened at $20.88 on Wednesday. Covetrus has a fifty-two week low of $13.39 and a fifty-two week high of $21.20. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.08 and a current ratio of 1.88. The company has a market capitalization of $2.93 billion, a P/E ratio of -208.80 and a beta of 1.63. The stock has a fifty day moving average of $20.83 and a 200-day moving average of $19.09.
Covetrus (NASDAQ:CVET – Get Rating) last posted its earnings results on Thursday, August 4th. The company reported $0.20 earnings per share for the quarter, hitting analysts' consensus estimates of $0.20. Covetrus had a positive return on equity of 6.83% and a negative net margin of 0.28%. The company had revenue of $1.22 billion during the quarter, compared to the consensus estimate of $1.23 billion. On average, equities analysts expect that Covetrus will post 0.84 EPS for the current year.Insider Activity at Covetrus
In related news, CEO Benjamin Wolin sold 5,292 shares of the business's stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $20.80, for a total value of $110,073.60. Following the completion of the transaction, the chief executive officer now owns 199,780 shares of the company's stock, valued at $4,155,424. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.40% of the stock is owned by insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Crossmark Global Holdings Inc. acquired a new position in Covetrus in the first quarter valued at about $170,000. Profund Advisors LLC grew its position in Covetrus by 19.6% in the first quarter. Profund Advisors LLC now owns 15,485 shares of the company's stock valued at $260,000 after acquiring an additional 2,543 shares during the last quarter. D. E. Shaw & Co. Inc. grew its position in Covetrus by 87.1% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,028,735 shares of the company's stock valued at $20,544,000 after acquiring an additional 479,008 shares during the last quarter. Campbell & CO Investment Adviser LLC bought a new position in Covetrus in the first quarter valued at about $343,000. Finally, Tamarack Advisers LP bought a new position in Covetrus in the first quarter valued at about $2,166,000. Institutional investors and hedge funds own 92.20% of the company's stock.
Covetrus Company Profile
(Get Rating)
Covetrus, Inc, together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.
Featured Stories
- Get a free copy of the StockNews.com research report on Covetrus (CVET)
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- Declining Profits Challenge the CarMax Value Proposition
- Let Paychex Stock Work Hard For You
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.
TheStreet upgraded shares of Covetrus (NASDAQ:CVET – Get Rating) from a d+ rating to a c- rating in a report published on Wednesday morning, TheStreetRatingsTable reports.
據The StreetRatingsTable報道,在週三上午發佈的一份報告中,華爾街將納斯達克(Covetrus:CVET-GET Rating)的股票評級從D+上調至C-。
Separately, Stifel Nicolaus downgraded Covetrus from a buy rating to a hold rating and set a $22.00 target price for the company. in a report on Monday, June 13th. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Hold and an average target price of $21.40.
另外,Stifel Nicolaus將Covetrus的評級從買入下調至持有,併為該公司設定了22.00美元的目標價。在6月13日星期一的一份報告中。一名投資分析師對該股的評級為賣出,五名分析師對該股的評級為持有。根據MarketBeat.com的數據,該股目前的普遍評級為持有,平均目標價為21.40美元。
Covetrus Stock Down 0.1 %
雪茄類股下跌0.1%
CVET opened at $20.88 on Wednesday. Covetrus has a fifty-two week low of $13.39 and a fifty-two week high of $21.20. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.08 and a current ratio of 1.88. The company has a market capitalization of $2.93 billion, a P/E ratio of -208.80 and a beta of 1.63. The stock has a fifty day moving average of $20.83 and a 200-day moving average of $19.09.
CVeT週三開盤報20.88美元。Covetrus的52周低點為13.39美元,52周高位為21.20美元。該公司的負債權益比率為0.65,速動比率為1.08,流動比率為1.88。該公司市值29.3億美元,市盈率為-208.80,貝塔係數為1.63.該股的50日移動均線切入位為20.83美元,200日移動均線切入位為19.09美元。
Insider Activity at Covetrus
Covetrus的內幕活動
In related news, CEO Benjamin Wolin sold 5,292 shares of the business's stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $20.80, for a total value of $110,073.60. Following the completion of the transaction, the chief executive officer now owns 199,780 shares of the company's stock, valued at $4,155,424. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.40% of the stock is owned by insiders.
在相關新聞中,首席執行官本傑明·沃林在日期為8月9日(星期二)的交易中出售了5,292股該公司股票。這隻股票的平均售價為20.80美元,總價值為110,073.60美元。交易完成後,首席執行官現在擁有199,780股公司股票,價值4,155,424美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可以通過美國證券交易委員會網站。該公司0.40%的股份由內部人士持有。
Institutional Inflows and Outflows
機構資金流入和流出
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Crossmark Global Holdings Inc. acquired a new position in Covetrus in the first quarter valued at about $170,000. Profund Advisors LLC grew its position in Covetrus by 19.6% in the first quarter. Profund Advisors LLC now owns 15,485 shares of the company's stock valued at $260,000 after acquiring an additional 2,543 shares during the last quarter. D. E. Shaw & Co. Inc. grew its position in Covetrus by 87.1% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,028,735 shares of the company's stock valued at $20,544,000 after acquiring an additional 479,008 shares during the last quarter. Campbell & CO Investment Adviser LLC bought a new position in Covetrus in the first quarter valued at about $343,000. Finally, Tamarack Advisers LP bought a new position in Covetrus in the first quarter valued at about $2,166,000. Institutional investors and hedge funds own 92.20% of the company's stock.
對衝基金和其他機構投資者最近買賣了該股的股票。今年第一季度,Crossmark Global Holdings Inc.收購了Covetrus的一個新頭寸,價值約為17萬美元。Profund Advisors LLC在第一季度將其在Covetrus的頭寸增加了19.6%。Profund Advisors LLC現在擁有15,485股該公司的股票,價值260,000美元,在上個季度又購買了2,543股。D.E.Shaw&Co.Inc.在第四季度將其在Covetrus的頭寸增加了87.1%。D.E.Shaw&Co.Inc.在上個季度增持了479,008股後,現在持有1,028,735股該公司股票,價值20,544,000美元。Campbell&CO Investment Adviser LLC在第一季度購買了Covetrus的新頭寸,價值約343,000美元。最後,Tamarack Advisers LP在第一季度購買了Covetrus的一個新頭寸,價值約為2,166,000美元。機構投資者和對衝基金持有該公司92.20%的股票。
Covetrus Company Profile
Covetrus公司簡介
(Get Rating)
(獲取評級)
Covetrus, Inc, together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.
Covetrus,Inc.及其子公司是一家動物保健技術和服務公司。它從事向批發和零售客户銷售動物健康消耗品,包括專利和Covetrus品牌產品、小型設備、實驗室產品、大型設備、設備維修服務、品牌和仿製藥、疫苗、外科產品、診斷測試、感染控制產品、寄生蟲藥以及維生素和補充劑。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Covetrus (CVET)
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- Declining Profits Challenge the CarMax Value Proposition
- Let Paychex Stock Work Hard For You
- 免費獲取StockNews.com關於Covetrus的研究報告(CVeT)
- MarketBeat:回顧一週9/26-9/30
- 這是買入美光科技的難忘時刻
- 雷神工業走出谷底
- 利潤下降對CarMax價值主張的挑戰
- 讓Paychex股票為您努力工作
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《椰子日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Covetrus和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧